Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States - PubMed (original) (raw)
Comparative Study
. 2007 Nov 14;298(18):2155-63.
doi: 10.1001/jama.298.18.2155.
Affiliations
- PMID: 18000199
- DOI: 10.1001/jama.298.18.2155
Comparative Study
Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States
Sandra W Roush et al. JAMA. 2007.
Abstract
Context: National vaccine recommendations in the United States target an increasing number of vaccine-preventable diseases for reduction, elimination, or eradication.
Objective: To compare morbidity and mortality before and after widespread implementation of national vaccine recommendations for 13 vaccine-preventable diseases for which recommendations were in place prior to 2005.
Design, setting, and participants: For the United States, prevaccine baselines were assessed based on representative historical data from primary sources and were compared to the most recent morbidity (2006) and mortality (2004) data for diphtheria, pertussis, tetanus, poliomyelitis, measles, mumps, rubella (including congenital rubella syndrome), invasive Haemophilus influenzae type b (Hib), acute hepatitis B, hepatitis A, varicella, Streptococcus pneumoniae, and smallpox.
Main outcome measures: Number of cases, deaths, and hospitalizations for 13 vaccine-preventable diseases. Estimates of the percent reductions from baseline to recent were made without adjustment for factors that could affect vaccine-preventable disease morbidity, mortality, or reporting.
Results: A greater than 92% decline in cases and a 99% or greater decline in deaths due to diseases prevented by vaccines recommended before 1980 were shown for diphtheria, mumps, pertussis, and tetanus. Endemic transmission of poliovirus and measles and rubella viruses has been eliminated in the United States; smallpox has been eradicated worldwide. Declines were 80% or greater for cases and deaths of most vaccine-preventable diseases targeted since 1980 including hepatitis A, acute hepatitis B, Hib, and varicella. Declines in cases and deaths of invasive S pneumoniae were 34% and 25%, respectively.
Conclusions: The number of cases of most vaccine-preventable diseases is at an all-time low; hospitalizations and deaths have also shown striking decreases.
Similar articles
- Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
McIntyre P, Amin J, Gidding H, Hull B, Torvaldsen S, Tucker A, Turnbull F, Burgess M. McIntyre P, et al. Commun Dis Intell. 2000 Jun;Suppl:v-83. Commun Dis Intell. 2000. PMID: 12049363 Review. - Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R, Turnour C, Chiu C, McIntyre P. Menzies R, et al. Commun Dis Intell Q Rep. 2008 Jun;32 Suppl:S2-67. Commun Dis Intell Q Rep. 2008. PMID: 18711998 Review. - Status report on the Childhood Immunization Initiative: reported cases of selected vaccine-preventable diseases--United States, 1996.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1997 Jul 25;46(29):665-71. MMWR Morb Mortal Wkly Rep. 1997. PMID: 9237476 - Update: childhood vaccine-preventable diseases--United States, 1994.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1994 Oct 7;43(39):718-20. MMWR Morb Mortal Wkly Rep. 1994. PMID: 8090160 - The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015.
Pezzotti P, Bellino S, Prestinaci F, Iacchini S, Lucaroni F, Camoni L, Barbieri MM, Ricciardi W, Stefanelli P, Rezza G. Pezzotti P, et al. Vaccine. 2018 Mar 7;36(11):1435-1443. doi: 10.1016/j.vaccine.2018.01.065. Epub 2018 Feb 7. Vaccine. 2018. PMID: 29428176
Cited by
- Health Technology Assessment of Vaccines in Italy: History and Review of Applications.
Boccalini S, Ragusa R, Panatto D, Calabrò GE, Cortesi PA, Giorgianni G, Favaretti C, Bonanni P, Ricciardi W, de Waure C. Boccalini S, et al. Vaccines (Basel). 2024 Sep 24;12(10):1090. doi: 10.3390/vaccines12101090. Vaccines (Basel). 2024. PMID: 39460257 Free PMC article. - An Interrupted Time Series Analysis of the Impact of the COVID-19 Pandemic on Routine Vaccination Uptake in Kenya.
Ngigi M, Moride Y, Castilloux AM, Clemens SAC. Ngigi M, et al. Vaccines (Basel). 2024 Jul 23;12(8):826. doi: 10.3390/vaccines12080826. Vaccines (Basel). 2024. PMID: 39203951 Free PMC article. - The Impact of Motivational Interviewing and MOTIVE Tool Use by Pharmacists on Vaccine Acceptance.
Chen AMH, Anthony A, Balogun A, Pereira R, Cole JW. Chen AMH, et al. Pharmacy (Basel). 2024 Jul 24;12(4):114. doi: 10.3390/pharmacy12040114. Pharmacy (Basel). 2024. PMID: 39195843 Free PMC article. - Strategies used to improve vaccine uptake among healthcare providers: A systematic review.
de Koning R, Gonzalez Utrilla M, Spanaus E, Moore M, Lomazzi M. de Koning R, et al. Vaccine X. 2024 Jul 2;19:100519. doi: 10.1016/j.jvacx.2024.100519. eCollection 2024 Aug. Vaccine X. 2024. PMID: 39105135 Free PMC article. Review. - Impact of National Immunization Strategies on Vaccine-Preventable Diseases - China, 1950-2021.
Song Q, Li Y, Cao L, Hao L, Wen N, Wang F, Ma C, Zhang G, Zheng H, Yu W, An Z, Yin Z, Wang H. Song Q, et al. China CDC Wkly. 2024 Apr 19;6(16):339-343. doi: 10.46234/ccdcw2024.064. China CDC Wkly. 2024. PMID: 38736466 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical